Recent Advances in Polyendocrine Metabolic Ovarian Syndrome: Endocrine and Metabolic Dysfunction and Cardiovascular Risk

Previously known as PCOS, polyendocrine metabolic ovarian syndrome (PMOS) is increasingly recognized as a lifelong metabolic and cardiovascular condition - not simply a reproductive disorder. A new review highlights the role of insulin resistance, the increased risk of type 2 diabetes and cardiovascular events, and why early metabolic screening matters, even in women without obesity.

source: JIM

Summary

[Posted 16/Nov/2026]

AUDIENCE: Internal Medicine, Endocrinology, Ob/Gyn

KEY FINDINGS: The change from PCOS to PMOS reflects a broader understanding of the condition and its implications beyond ovarian function. The review identifies several clinically relevant considerations:

  • Metabolic screening: Glycemic assessment at least every 3 years, with shorter intervals for higher-risk individuals.
  • Preferred testing: A 75-g oral glucose tolerance test is recommended for assessing glycemic status.
  • Cardiovascular prevention: Assessment should consider blood pressure, lipid abnormalities, central adiposity and other metabolic risk factors.
  • Risk beyond obesity: Normal BMI does not exclude insulin resistance or increased cardiovascular risk.
  • Individualized treatment: Lifestyle interventions, metformin, weight-management therapies and reproductive treatments should be tailored to clinical presentation and reproductive plans.

BACKGROUND: PMOS affects an estimated 10%–13% of women of reproductive age and remains underdiagnosed. Historically viewed mainly as a reproductive condition, it is now recognized as a complex endocrine and metabolic disorder with reproductive, psychological, dermatological and cardiometabolic consequences. The change in nomenclature reflects a broader understanding of the condition. The term PCOS can be misleading because the ovarian appearance typically involves arrested follicles rather than an increased number of pathological ovarian cysts. The updated terminology is intended to better represent the condition's underlying biology and its effects beyond the ovaries.

DETAILS: Insulin resistance as the central mechanism Insulin resistance is a defining feature of PMOS and is reported in 75% of lean women and 95% of overweight women when measured using euglycemic–hyperinsulinemic clamps. Unlike insulin resistance associated primarily with obesity, the condition appears to involve an intrinsic, tissue-specific defect that can occur independently of excess adiposity. Compensatory hyperinsulinemia contributes to increased ovarian and adrenal androgen production, reduced hepatic sex hormone-binding globulin (SHBG), and disrupted follicular development. These processes reinforce one another, linking metabolic dysfunction with hyperandrogenism and ovulatory abnormalities.

Our Most Popular Resources

Diabetes and metabolic complications

A pooled analysis of 41 studies reported increased odds of impaired fasting glucose (OR 3.2), impaired glucose tolerance (OR 3.9), and type 2 diabetes (OR 2.9) in women with PMOS. Importantly, the increased diabetes risk is also observed in women without obesity. The review highlights the importance of regular glycemic surveillance. The 2023 International Evidence-Based Guideline recommends testing at least every 3 years, with more frequent assessment for women with additional risk factors, including previous gestational diabetes, family history of type 2 diabetes and elevated BMI. A 75-g oral glucose tolerance test is identified as the preferred assessment method, although practical limitations affect its accessibility. Metabolic dysfunction-associated steatotic liver disease (MASLD) is another important complication. A pooled prevalence of 43% has been reported among women with PMOS, with insulin resistance, metabolic syndrome and biochemical hyperandrogenism identified as associated risk factors.

Cardiovascular risk

The review presents evidence that cardiovascular complications emerge earlier in women with PMOS than in the general female population. The condition is associated with a 20%–70% increased risk of cardiovascular disease, depending on the population studied, and an approximately 3-fold increased risk of type 2 diabetes.

Atherogenic dyslipidemia affects 60%–70% of women with PMOS, typically involving elevated triglycerides, reduced HDL cholesterol and increased small dense LDL particles. Hypertension occurs 2–3-fold more frequently than in age-matched controls. Central obesity, chronic inflammation and endothelial dysfunction further contribute to cardiovascular risk. Population-based studies provide evidence of increased cardiovascular events, not merely an unfavourable risk-factor profile. A Danish cohort comparing 18,112 women with PMOS with 54,336 matched controls reported an increased incidence of cardiovascular disease (HR 1.71; 95% CI, 1.56–1.88). Risks were also elevated for myocardial infarction (HR 1.78) and ischemic heart disease (HR 1.73).

A Nordic population-based cohort of nearly 130,000 women reported an increased risk of cardiovascular disease (HR 1.27 [1.18; 1.36]), major adverse cardiovascular events (1.21 [1.10; 1.34]) and deep venous thrombosis (1.30 [1.27; 1.33]). Cardiovascular risk was also elevated among women with a BMI below 25 kg/m² (HR 1.40 [1.26; 1.55]). Notably, cardiovascular risk curves began to diverge at approximately 35 years of age in population-based studies, emphasizing the importance of early identification and preventive care.

Management and emerging treatment approaches

Lifestyle intervention, including structured exercise, balanced nutrition and behavioural strategies, remains the foundation of management. Metformin is recommended particularly for adults with a BMI of 25 kg/m² or higher, with benefits for insulin sensitivity and glycemic outcomes. GLP-1 receptor agonists may provide greater weight reduction than metformin, although evidence specifically in PMOS remains limited. A systematic review of 11 randomized controlled trials reported a reduction in BMI of 1.38 kg/m² (95% CI 0.38–2.39 kg/m²). These medications are contraindicated during pregnancy, and effective contraception is recommended during treatment. For severe obesity, bariatric surgery may improve weight, diabetes, hypertension, ovulation and fertility. Treatment decisions should be individualized according to metabolic risk, clinical manifestations and reproductive goals.

The review reinforces PMOS as a lifelong multisystem endocrine and metabolic disorder rather than an isolated reproductive condition. Insulin resistance and compensatory hyperinsulinemia provide an important biological link between reproductive dysfunction, type 2 diabetes and cardiovascular disease. Population-based evidence indicates that cardiovascular risk may emerge from early adulthood, including in women without obesity. The authors emphasize early diagnosis, systematic metabolic surveillance, cardiovascular risk assessment and individualized interventions as priorities for improving long-term outcomes.

The article is a review of evolving evidence, not a new clinical trial. Several therapeutic approaches remain supported by limited or low-quality evidence, and further research is needed to develop validated cardiovascular risk-prediction tools and long-term prevention strategies.

Copyright © Skyscape. All rights reserved.

Source: Forslund, M., Melin, J., Joham, A.E., et al. Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk. Journal of Internal Medicine. 2026; Published: August 30, 2026. DOI: 10.1111/joim.70156.



Focal Congenital Hyperinsulinism: Spontaneous Glycemic Improvement Before Surgery

Could some infants with focal congenital hyperinsulinism improve without pancreatic surgery? A retrospective study found that approximately 30% showed early glycemic improvement, with some achieving spontaneous resolution of hypoglycemia. The findings highlight the importance of individualized surgical decisions and careful monitoring.

source: JCEM

Summary

[Posted 18/Nov/2026]

AUDIENCE: Endocrinology, Cardiology, Internal Medicine

KEY FINDINGS: Approximately 30% of infants with FoCHI showed early spontaneous glycemic improvement. Although surgery remains the standard curative treatment, carefully selected infants with favourable early glucose control may be considered for conservative management, particularly when pancreatic head surgery carries substantial risk. The predictive score is exploratory and requires further validation. Close glucose monitoring and specialist assessment remain essential before deferring surgery.

BACKGROUND: Congenital hyperinsulinism (CHI) is the most common genetic cause of hypoglycemia in infants. In focal congenital hyperinsulinism (FoCHI), excessive insulin secretion originates from a localized pancreatic lesion that can often be surgically removed. However, surgery, particularly involving the pancreatic head, carries a risk of postoperative complications.

DETAILS: Researchers retrospectively reviewed 39 patients treated at a single referral centre. Patients were classified according to whether continuous gastric tube feeding was required to maintain glucose control: 12 patients (30.8%) were in the no-tube-feeding (NTF) group and 27 (69.2%) in the tube-feeding (TF) group. The NTF group had later diagnosis (P = .022) and less severe initial hypoglycemia (P = .003). An exploratory predictive score for early disease evolution demonstrated 97% specificity.

Our Most Popular Resources

Four of the 12 patients in the NTF group experienced spontaneous resolution of hypoglycemia before 6 years of age and did not require surgery. Surgery was curative in 96.3% of the TF group and 100% of the NTF group. Long-term complications occurred in 8.6% and 0%, respectively, and consisted exclusively of exocrine pancreatic insufficiency. This complication occurred only after pancreatic head surgery, affecting 15.8% of patients undergoing that procedure.

Copyright © Skyscape. All rights reserved.

Source: Arnoux, J. B., Mayer, C., Jhaouat, I., et al. Focal congenital hyperinsulinism: spontaneous glycemic improvement before surgery. The Journal of Clinical Endocrinology & Metabolism. 2026; 111(11): 3032-3041. Published: November 22, 2026. DOI: 10.1210/clinem/dgag227.



Severe Symptomatic Hypocalcemia Associated With Long-Term Pantoprazole Use

Long-term pantoprazole use may have important electrolyte consequences. This case report describes severe hypocalcemia presenting with carpopedal spasms and QTc prolongation, highlighting the importance of reviewing prolonged PPI therapy and evaluating calcium and magnesium abnormalities.

source: Int J Emerg Med

Summary

A Case Report

[Posted 17/Nov/2026]

AUDIENCE: Emergency Medicine, Endocrinology, Internal Medicine

KEY FINDINGS: Long-term PPI use may contribute to impaired calcium homeostasis through hypomagnesemia and reduced PTH secretion or responsiveness. Clinicians should consider electrolyte disturbances in patients presenting with unexplained muscle spasms, paresthesia or QTc prolongation.

BACKGROUND: Long-term proton pump inhibitor (PPI) therapy has been associated with mineral metabolism disturbances, particularly hypomagnesemia, which can interfere with calcium regulation. This case highlights a rare but serious presentation of symptomatic hypocalcemia in a patient taking pantoprazole for several years. Springer Nature Link

DETAILS: A 54-year-old woman presented with progressive weakness, tingling sensations and painful involuntary muscle contractions. Examination revealed bilateral carpopedal spasms and positive Trousseau’s and Chvostek’s signs. ECG showed QTc prolongation. Laboratory investigations revealed severe hypocalcemia, with total calcium of 5.2 mg/dL and ionized calcium of 0.74 mmol/L. She also had mild hypomagnesemia (1.5 mg/dL), vitamin D insufficiency (18 ng/mL) and an inappropriately low parathyroid hormone level (13 pg/mL).

Our Most Popular Resources

The patient had been self-administering pantoprazole 40 mg daily for approximately four years without regular medical reassessment. Treatment included discontinuation of pantoprazole, intravenous calcium gluconate under cardiac monitoring, magnesium and vitamin D supplementation, followed by oral calcium therapy. Neuromuscular symptoms improved within 24 hours of treatment. At one-month follow-up, the patient remained asymptomatic, with normalized calcium and magnesium levels and improved vitamin D status.

Important limitation: This single case cannot establish that pantoprazole directly caused hypocalcemia. Vitamin D insufficiency and impaired PTH response may also have contributed.

Copyright © Skyscape. All rights reserved.

Source: Khaneghahi, A., Zamani, S., Akbari, M., et al. evere symptomatic hypocalcemia with neuromuscular hyperexcitability associated with long-term pantoprazole use: a case report. International Journal of Emergency Medicine. 2026; 19:261. Published: October 6, 2026. DOI: 10.1186/s12245-026-01398-5.



Disentangling the Causal Effects of Education and Participation Bias on Alzheimer Disease Using Mendelian Randomization

Does higher educational attainment genuinely reduce Alzheimer's disease risk, or could research participation bias influence this association? A Mendelian randomization study suggests that the relationship between education and clinically diagnosed Alzheimer's disease persists even after accounting for participation-related factors.

source: Neuro Genetics

Summary

[Posted 14/Nov/2026]

AUDIENCE: Neurology, Psychiatry

KEY FINDINGS: The findings support an association between higher educational attainment and reduced risk of clinically diagnosed AD that persists after accounting for research participation. This suggests that the potential protective effect of education may involve mechanisms beyond differences in study enrollment, including cognitive reserve. The contrasting findings for clinically diagnosed AD and AD/ADRD highlight the importance of outcome definition in genetic epidemiological research. Studies relying partly on family history or proxy diagnoses may be more vulnerable to selection and ascertainment biases than those using confirmed clinical diagnoses.

Clinicians and researchers should interpret epidemiological associations between education and dementia with consideration of potential participation bias and differences in diagnostic ascertainment. Although the study strengthens evidence for an independent relationship between education and clinically diagnosed AD, Mendelian randomization findings do not establish that increasing educational attainment later in life will directly prevent Alzheimer's disease. Further research using more representative populations and stronger multivariable genetic instruments is warranted. An important limitation is that the genetic datasets were restricted to individuals of European ancestry, which may limit generalizability to other populations.

BACKGROUND: Higher educational attainment has consistently been associated with a lower incidence of Alzheimer's disease (AD). However, this relationship may partly reflect selection and participation biases rather than a direct protective effect of education. Individuals with higher educational levels may be more likely to participate in clinical research, while people with cognitive impairment may be less likely to complete assessments or enroll in studies. These differences can distort observed associations between education and AD risk. This study investigated whether the association between educational attainment and AD reflects a genuine causal relationship or is influenced by participation-related biases. Semantic Scholar

DETAILS: Chatterjee and colleagues conducted a two-sample Mendelian randomization (MR) study using genome-wide association study (GWAS) summary statistics to examine the relationships among educational attainment, research participation, and AD. The analysis incorporated genetic data for educational attainment, three measures of research participation, clinically diagnosed AD, and AD and related dementias (AD/ADRD), which included clinical diagnoses and family history information.

Our Most Popular Resources

The investigators used fixed-effects inverse variance-weighted analysis as the primary MR approach. Additional analyses included MR-Egger regression, weighted median and mode-based estimators, bidirectional MR, and multivariable Mendelian randomization (MVMR). These methods were used to assess potential confounding, genetic pleiotropy, reverse causation, and the independent effects of education and participation. The educational attainment dataset included 3,037,499 participants, while the primary participation measure, based on completion of an optional UK Biobank Mental Health Questionnaire, included 451,036 participants. The clinically diagnosed AD dataset included 94,437 participants, and the AD/ADRD dataset included 788,989 participants. All included GWAS cohorts were of European ancestry. Semantic Scholar

Genetically predicted educational attainment was associated with a reduced risk of clinically diagnosed AD. Each additional year of education was associated with lower odds of AD (OR, 0.70; 95% CI, 0.63–0.79; p = 8e-10). This association remained significant after adjustment for participation in the multivariable MR analysis (OR, 0.76; 95% CI, 0.62–0.92; p = 0.006), suggesting that participation bias alone did not explain the protective association. However, educational attainment was also associated with increased odds of AD/ADRD (OR, 1.09; 95% CI, 1.02–1.15; p = 0.006). This finding was not supported by sensitivity analyses, indicating that the association was not robust.

Participation in the optional Mental Health Questionnaire was associated with reduced odds of clinically diagnosed AD (OR, 0.325; 95% CI, 0.128–0.326; p = 0.01). Genetic liability to AD was also associated with reduced participation in the questionnaire, suggesting that disease-related factors may influence research enrollment and contribute to selection bias. After adjustment for education, there was limited evidence that participation independently influenced AD risk (OR, 0.58; 95% CI, 0.22–1.51; p = 0.27). The authors also identified low conditional instrument strength in the multivariable analysis, which limits the precision of causal interpretation. Semantic Scholar

Copyright © Skyscape. All rights reserved.

Source: Chatterjee, A., Cavaillès, C., Davies, N. M., et al. Disentangling the Causal Effects of Education and Participation Bias on Alzheimer Disease Using Mendelian Randomization. XXXX. 2025; 11(6): e200307. Published: December, 2025. DOI: 10.1212/NXG.0000000000200307.



A Human Gut-Associated Picobirnavirus Establishes the Picobirnaviridae as the Third Clade of RNA Bacteriophages

A virus frequently detected in human stool may not infect human cells at all. New research identifies a human gut-associated picobirnavirus as an RNA bacteriophage, revealing a previously unrecognized bacterial host and establishing Picobirnaviridae as the third major clade of RNA phages.

source: Nat Microbiol

Summary

[Posted 13/Nov/2026]

AUDIENCE: Gastroenterology, Infectious Disease, Internal Medicine

KEY FINDINGS: The study changes the interpretation of picobirnaviruses detected in human and animal specimens. Their presence in stool does not necessarily indicate direct infection of the host or zoonotic transmission; the same virus may instead be detected in different animals because they carry the same bacterial species. The findings also have implications for research into the gut microbiome and human disease. Although PBVs have previously been associated with several clinical conditions, this study does not establish a causal role in those diseases. If PBVs are predominantly bacterial viruses, their potential effects on health may involve changes in bacterial populations and microbiome function.

The authors acknowledge that the host range of PBVs remains uncertain and that the findings from PBV-18941 cannot automatically be generalized to every member of the Picobirnaviridae family. Further work is needed to characterize additional PBVs, establish their bacterial hosts and determine whether they influence disease-associated microbial communities.

BACKGROUND: This study challenges the traditional understanding of picobirnaviruses as viruses associated with eukaryotic hosts. It presents evidence that a human gut-associated picobirnavirus belongs to a distinct lineage of RNA bacteriophages—viruses that infect bacteria—positioning the family Picobirnaviridae as a third major clade of RNA bacteriophages.

Picobirnaviruses (PBVs) are double-stranded RNA viruses frequently detected in faecal samples from humans and animals. They have been associated with several conditions, including diarrhoea, enteric graft-versus-host disease, irritable bowel syndrome and type 1 diabetes in pregnant women. However, these associations have not established that PBVs directly infect vertebrate cells or cause disease. Despite their widespread detection, PBVs had remained difficult to characterize because no reliable culture system or animal model was available. Their true biological hosts were therefore uncertain. The possibility that they infect microorganisms living in the gut, rather than human or animal cells, had been proposed but not experimentally established.

DETAILS: Researchers investigated two previously unreported PBVs identified in human stool samples collected in the United Kingdom. The viruses, designated PBV-18941 and PBV-19022, were first propagated in germ-free mice following faecal microbiota transplantation. Viral RNA increased substantially in at least one mouse for each virus: PBV-18941 increased 10⁷-fold and PBV-19022 increased 10⁶-fold. Both persisted through day 23. Further experiments demonstrated that PBV-19022 could be serially propagated in mice. Neomycin treatment eventually eliminated the virus, suggesting a possible relationship with an antibiotic-sensitive bacterial host. The investigators subsequently established an anaerobic in vitro culture system using the gut microbial community from PBV-positive mouse stool. PBV-18941, but not PBV-19022, persisted through 20 passages. Its growth was eliminated by neomycin, vancomycin and metronidazole, providing further evidence that bacterial growth was necessary for its propagation.

Our Most Popular Resources

RNA fluorescence in situ hybridization demonstrated that both genomic segments of PBV-18941 were present inside bacterial cells. Fluorescence-activated cell sorting and sequencing identified a previously undescribed Anaerotignum species, proposed as ‘Candidatus Anaerotignum faecalis', as the bacterial host. PBV RNA was detected in this organism but not in the other prominent bacterial species identified in the sorted community. The identified bacterium represented approximately 0.3% of the total bacterial community, and approximately 10% of its cells were infected by PBV-18941. The researchers were unable to isolate ‘Ca. A. faecalis' as a pure culture, which remains an important limitation.

The findings provide direct experimental evidence that PBV-18941 infects bacteria rather than vertebrate cells, establishing it as an RNA bacteriophage. The study therefore identifies Picobirnaviridae as the third recognized clade of RNA bacteriophages, alongside leviviruses and cystoviruses. Importantly, PBV-18941 infects a Gram-positive bacterium, expanding the known host range of characterized RNA phages, which had previously been associated primarily with Gram-negative bacteria.

Copyright © Skyscape. All rights reserved.

Source: Gan, T., Rosen, A. L., Wang, L., et al. A human gut-associated picobirnavirus establishes the Picobirnaviridae as the third clade of RNA bacteriophages. Nature Microbiology. Published: October 29, 2026. DOI: 10.1038/s41564-026-02523-z.



Picosecond Laser Treatment May Trigger Koebner Phenomenon in Patients With Psoriasis: Clinical and Immunopathological Findings

Can cosmetic laser procedures trigger psoriasis flare-ups, even in patients with well-controlled disease? A case report describes the development of new psoriatic lesions following picosecond laser treatment, highlighting a potential link between photomechanical skin injury and the Koebner phenomenon.

source: Lasers Surg. Med.

Summary

[Posted 9/Nov/2026]

AUDIENCE: General Surgery, Dermatology

KEY FINDINGS: This case highlights a potential dermatological complication of picosecond laser procedures in patients with psoriasis, even when the underlying disease is clinically well controlled. Although these lasers are designed to minimize thermal injury, their photomechanical effects may trigger cutaneous inflammation and new psoriatic lesions through the Koebner phenomenon.

Clinicians should assess baseline psoriasis activity, avoid treating active psoriatic plaques, and discuss the possibility of postprocedural lesion development before elective laser procedures. A test spot and early post-treatment monitoring may also be considered.

The findings are based on a single case report with four months of follow-up and cannot establish the incidence or magnitude of this risk. Further clinical observations are required to determine the safety profile of picosecond laser procedures in patients with psoriasis. Wiley Online Library

BACKGROUND: The Koebner phenomenon (KP), also known as the isomorphic response, refers to the development of disease-specific skin lesions at sites of cutaneous injury. It is a recognized feature of psoriasis and may occur following mechanical trauma or dermatological procedures. Picosecond lasers are increasingly used for cosmetic dermatological treatments because their ultrashort pulses produce predominantly photomechanical effects with limited thermal damage. However, the potential of these laser-induced effects to trigger psoriatic lesions has not been well characterized. This case report describes the development of the Koebner phenomenon following picosecond laser treatment in a patient with previously controlled plaque psoriasis. Wiley Online Library

DETAILS: The report describes a 58-year-old woman with well-controlled plaque psoriasis who underwent 755-nm picosecond alexandrite laser treatment for seborrheic keratoses on her back and lower waist. The laser was administered with a pulse duration of 750 ps, fluence of 3.77 J/cm², and spot size of 3 mm, using five passes. Her baseline psoriasis was mild, with a Psoriasis Area and Severity Index (PASI) score of 3.6, and was being managed with topical calcipotriol/betamethasone dipropionate.

Our Most Popular Resources

No immediate adverse reaction was observed. However, one month after treatment, erythematous, scaly plaques appeared exclusively at the laser-treated sites. Dermoscopic examination demonstrated characteristic psoriatic features, while histopathological assessment revealed elongated rete ridges, parakeratosis, and inflammatory cell infiltration. Immunohistochemical analysis demonstrated dermal predominance of CD4-positive T cells and increased CD8-positive T cells in the epidermis. Interestingly, no Koebner response developed in an adjacent melanocytic nevus treated with a CO₂ laser.

The clinical, dermoscopic, histopathological, and immunohistochemical findings confirmed the development of the Koebner phenomenon following picosecond laser exposure.

The psoriatic plaques resolved completely after four weeks of topical corticosteroid treatment, with no recurrence during the subsequent four-month follow-up period.

The authors proposed that the photomechanical effects of picosecond lasers may produce acoustic microtrauma capable of activating inflammatory and immune pathways involved in psoriasis. The contrasting response observed at the CO₂ laser-treated site was considered hypothesis-generating rather than evidence of a definitive difference in laser-associated risk. Wiley Online Library

Copyright © Skyscape. All rights reserved.

Source: Sakai, T., Sonoda, K., and Omatsu, J. Triggering of Koebner Phenomenon by Picosecond Laser in a Psoriatic Patient: Clinical and Immunopathologic Insights. Lasers in Surgery and Medicine. 2026; 58(9):745–749. Published: June 30, 2026. DOI: 10.1002/lsm.70171.



Specialty: 

Breaking Medical News Cardiology Dermatology Emergency Medicine Endocrinology Family Medicine Gastroenterology General Interests General Surgery Hematology/Oncology Infectious Disease Internal Medicine Nephrology Neurology Nursing Ob/Gyn Ophthalmology Palliative Hospice Pediatrics Pharmacy Psychiatry